Welcome to our dedicated page for Xebra Brands news (Ticker: XBRAF), a resource for investors and traders seeking the latest updates and insights on Xebra Brands stock.
Xebra Brands Ltd. (XBRAF) generates frequent corporate and regulatory updates that are relevant for investors following cannabis and wellness companies. Its news flow covers both operational developments and capital markets events across its activities in Mexico, Canada and the United States.
In its releases, Xebra reports on the development and commercialization of cannabis‑derived wellness products, including its ELEMENTS™ CBD product line and Vicious Citrus THC/CBN lemonades. News items have described progress toward the U.S. launch of ELEMENTS™, such as finalized product formulations, packaging and e‑commerce planning, as well as integration into logistics and fulfillment infrastructure.
The company’s disclosures also address regulatory milestones and authorizations. Xebra highlights its authorization from COFEPRIS in Mexico to import, cultivate, manufacture and sell cannabis with less than 1% THC, and provides updates on how this supports its international cannabis cultivation and product strategy.
From a capital markets perspective, Xebra’s news includes information on management changes, loan agreements with existing shareholders, warrant expiry extensions, and share consolidation plans on a ten‑for‑one basis. The company has also issued detailed updates on its management cease trade order and subsequent failure‑to‑file cease trade order related to delayed financial statement filings, as well as the impact on trading of its securities on the Canadian Securities Exchange and its move from the OTCQB Market to the OTC Pink Open Market.
Readers of the XBRAF news page can expect coverage of product commercialization efforts, regulatory authorizations, financing and corporate structure changes, and filing status reports. Monitoring these releases can help track how Xebra manages its cannabis‑derived product portfolio, regulatory relationships and listing status over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has received a court extension from the Mexican Health Regulatory Agency (COFEPRIS) to grant cannabis authorizations, now expected by the week of February 6. These authorizations will focus on cannabis with low levels of THC, primarily for hemp products and CBD sales. The company also announces significant management changes, including the resignation of founder Robert Giustra as Chairman to pursue mining ventures, along with CFO Andrew Yau and Corporate Secretary Daniela Freitas. Rodrigo Gallardo is appointed as the interim CFO and Corporate Secretary.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) announces a favorable ruling from a District Court regarding cannabis authorizations in Mexico. The court dismissed a resolution by COFEPRIS, the Mexican health regulatory agency, as insufficient. It ordered COFEPRIS to issue full authorizations within three business days, although delays are anticipated due to holiday closures. The authorizations will apply to low-THC cannabis, focusing on hemp cultivation and CBD products, with potential opportunities in hemp plastics.
Xebra Brands Ltd. (CSE: XBRA, OTCQB: XBRAF) has announced progress regarding cannabis authorizations in Mexico. The Mexican Health Regulatory Agency, COFEPRIS, has notified Xebra Mexico that it has complied with a Supreme Court mandate for cannabis authorizations. However, Xebra asserts that COFEPRIS has not fully met this mandate and has sought federal judicial intervention. The authorizations will mainly pertain to low-THC cannabis (under 1%) for hemp cultivation and CBD products. Delays in the authorization process are anticipated due to the lack of legal precedent in Mexico.